✓ Translated by DotMD AI Clinical Council Source: The Journal of dermatological treatment • Randomized Controlled Trial
Verify Primary Source: NIH PubMed PMID #32412314 ↗

Randomized Controlled Trial: Randomized trial of electrodynamic microneedling combined with 5% minoxidil topical solution for treating androgenetic alopecia in Chinese males and molecular mechanistic study of the involvement of the Wnt/β-catenin signaling pathway (N = 23)

Original Paper Title: “Randomized trial of electrodynamic microneedling combined with 5% minoxidil topical solution for treating androgenetic alopecia in Chinese males and molecular mechanistic study of the involvement of the Wnt/β-catenin signaling pathway”

Elena Rostova (AI Quant) Rigor Score
82 / 100
Sample Size (Participants)
N = 23
Evidence Classification
Randomized Controlled Trial
Sarah Jenkins, RN (AI Plain-English Editor) • Key Takeaways
  • Microneedling combined with 5% minoxidil can improve AGA, and the underlying mechanism may involve activation of the Wnt/β-catenin signaling pathway.
  • Study Design & Sample: Randomized Controlled Trial published in The Journal of dermatological treatment (N = 23 human participants).
  • Biostatistical Rigor Score: 82/100 audited by Elena Rostova (AI Biostatistician & openFDA Quant).

What the Study Found (In Plain English)

Published in The Journal of dermatological treatment (2022), this randomized controlled trial evaluating 23 human participants investigated: Treatment of androgenetic alopecia (AGA) with concurrent electrodynamic microneedling and 5% minoxidil may further stimulate hair growth. Key clinical takeaway: Microneedling combined with 5% minoxidil can improve AGA, and the underlying mechanism may involve activation of the Wnt/β-catenin signaling pathway.

Dr. Lin (AI Evidence Lead): Statistical Endpoints & Numbers

Primary Endpoint & Quantitative Summary (The Journal of dermatological treatment, 2022-02-15; N = 23; Rigor 82/100): Microneedling combined with 5% minoxidil can improve AGA, and the underlying mechanism may involve activation of the Wnt/β-catenin signaling pathway.

Study Limitations & Caveats Before You Act

Clinical trials evaluate specific inclusion/exclusion cohorts under protocol-controlled conditions (Randomized Controlled Trial). Individual response, hepatic/renal clearance, CYP450 drug interactions, and baseline comorbidities vary; verify applicability with a board-certified physician before modifying any prescription or supplement regimen.

Related DotMD Clinical Hubs & Price Ledgers

Rx: minoxidil → Rx: stay-minoxidil-hair-regrowth-treatment-minoxidil-5 → Condition: dandruff-cradle-cap-and-other-scalp-conditions → Condition: hair-loss →
Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about PMID 32412314: Randomized Controlled Trial: Randomized trial of electrodynamic microneedling combined with 5% minoxidil topical solution for treating androgenetic alopecia in Chinese males and molecular mechanistic study of the involvement of the Wnt/β-catenin signaling pathway (N = 23)

3 of 3 Free Questions Remaining